These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21243744)

  • 1. New ovarian cancer gene variations discovered. Findings may help target at-risk women for ovarian cancer screening and earlier treatment.
    Duke Med Health News; 2010 Dec; 16(12):4-5. PubMed ID: 21243744
    [No Abstract]   [Full Text] [Related]  

  • 2. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
    Brunsvold AN; Wung SF; Merkle CJ
    J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of genetic testing for inherited breast and ovarian cancer risk.
    Calzone KA
    Nurs Spectr (Wash D C); 1998 Nov; 8(23):12-4. PubMed ID: 10542772
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
    Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
    Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical concerns relating to the detection and treatment of ovarian cancer.
    Jansen LA
    Gynecol Oncol; 2002 Jan; 84(1):1-3. PubMed ID: 11748967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic predisposition and ovarian cancer].
    Coupier I; Gauthier-Villars M; This P; Stoppa-Lyonnet D
    Rev Prat; 2004 Oct; 54(16):1757-62. PubMed ID: 15630879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for ovarian cancer.
    Buckler A; Luu P
    Am Fam Physician; 2013 May; 87(10):709-10. PubMed ID: 23939449
    [No Abstract]   [Full Text] [Related]  

  • 12. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
    Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
    Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision.
    Friedenson B
    MedGenMed; 2001 Nov; 3(6):2. PubMed ID: 11965197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New genetic technologies: clinical application and ethical issues in familial ovarian cancer.
    Cole DE
    Clin Invest Med; 2004 Feb; 27(1):16-8. PubMed ID: 15061581
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for ovarian cancer prevention.
    Dann RB; Kelley JL; Zorn KK
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
    Maheu C; Thorne S
    Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing hereditary ovarian cancer.
    Mourits MJ; de Bock GH
    Maturitas; 2009 Nov; 64(3):172-6. PubMed ID: 19811881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the understanding of risk factors for ovarian cancer.
    Bandera CA
    J Reprod Med; 2005 Jun; 50(6):399-406. PubMed ID: 16050564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing for familial cancer. The French National Report (year 2003).
    Eisinger F
    Community Genet; 2008; 11(1):63-7. PubMed ID: 18196919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for ovarian cancer].
    Bjørge T; Dørum A; Tropé CG
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1444-8. PubMed ID: 10851943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.